Excellis Holding invests in deep-tech startups and university spin-offs founded or co-founded by Italian researchers abroad, focusing on technologies that will address global changes in the next decade, including health and well-being for an aging population.
About Excellis Holding
Excellis Holding is an Italian investment holding company headquartered in Italy with an Italian-language web presence and limited disclosure in English. The structure of an Italian holding rather than a fund typically signals patient family or founder capital deployed across operating businesses and minority equity positions rather than a venture portfolio with disclosed thesis, check size, and stage. Healthcare exposure, if any, is likely tied to the holding’s operating interests rather than a declared sector strategy; without further disclosure, founders should assume that any healthcare investment would be highly opportunistic and driven by relationship and Italian-market relevance rather than a programmatic mandate. AI focus is unstated. Without clear stage data, founders should not assume venture-style behavior at all; expect either control-oriented majority deals on operating businesses or selective minority positions in growth-stage Italian companies. This is not the right partner for a high-growth global software company seeking a venture lead, nor for founders outside the Italian-speaking commercial sphere. It is a plausible partner for Italian growth-stage healthcare operators, services rollups, or industrial-health businesses where Italian network and patient capital are valuable. Entry path is direct contact through the Italian website and, where possible, a warm introduction from a Milan or Rome corporate advisor; English-only outreach without an Italian commercial story is unlikely to land. Founders should be honest with themselves about whether holding-company capital matches their growth profile before pursuing a conversation.
Founder reviews
Other portfolio companies
Companies in Excellis Holding's portfolio not currently in our directory.
- MintNeuro · 2024
- Fluorok · 2024
- Nagi Bioscience · 2023
- Annaida Technologies · 2025
- Mentium Technologies · 2023
- Zaphiro Technologies SA · 2022
- vitrealab · 2026
- ToffeeX
- TOffeeAM · 2022
- DeepMirror · 2024
- Synthara Systems
- nodeQ
Team
Pitch / review this investor
Have you raised from Excellis Holding? Founders only — share your honest experience (anonymous OK, moderated before publishing).